PL91966B1 - - Google Patents
Download PDFInfo
- Publication number
- PL91966B1 PL91966B1 PL1970177342A PL17734270A PL91966B1 PL 91966 B1 PL91966 B1 PL 91966B1 PL 1970177342 A PL1970177342 A PL 1970177342A PL 17734270 A PL17734270 A PL 17734270A PL 91966 B1 PL91966 B1 PL 91966B1
- Authority
- PL
- Poland
- Prior art keywords
- group
- wzdr
- formula
- cho
- ccl3
- Prior art date
Links
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 27
- 150000001875 compounds Chemical class 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 11
- 229910052739 hydrogen Inorganic materials 0.000 claims description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- 238000002844 melting Methods 0.000 claims description 8
- 230000008018 melting Effects 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 238000000354 decomposition reaction Methods 0.000 claims description 6
- -1 2,4-dichlorophenoxymethyl group Chemical group 0.000 claims description 4
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims description 4
- 125000005843 halogen group Chemical group 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 229910052736 halogen Inorganic materials 0.000 claims description 3
- 150000002367 halogens Chemical class 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000011734 sodium Chemical group 0.000 claims description 3
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical class CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 2
- 239000003921 oil Substances 0.000 claims description 2
- 125000004429 atom Chemical group 0.000 claims 3
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 238000010992 reflux Methods 0.000 claims 2
- 239000011701 zinc Substances 0.000 claims 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- 239000012230 colorless oil Substances 0.000 claims 1
- 229910052802 copper Inorganic materials 0.000 claims 1
- 239000010949 copper Substances 0.000 claims 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims 1
- 239000011591 potassium Chemical group 0.000 claims 1
- 229910052700 potassium Inorganic materials 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- ZBZJXHCVGLJWFG-UHFFFAOYSA-N trichloromethyl(.) Chemical compound Cl[C](Cl)Cl ZBZJXHCVGLJWFG-UHFFFAOYSA-N 0.000 claims 1
- 229910052725 zinc Inorganic materials 0.000 claims 1
- 239000000243 solution Substances 0.000 description 19
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 10
- 238000003756 stirring Methods 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Substances CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 239000012043 crude product Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- QGJOPFRUJISHPQ-UHFFFAOYSA-N Carbon disulfide Chemical compound S=C=S QGJOPFRUJISHPQ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- AOSZTAHDEDLTLQ-AZKQZHLXSA-N (1S,2S,4R,8S,9S,11S,12R,13S,19S)-6-[(3-chlorophenyl)methyl]-12,19-difluoro-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-azapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one Chemical compound C([C@@H]1C[C@H]2[C@H]3[C@]([C@]4(C=CC(=O)C=C4[C@@H](F)C3)C)(F)[C@@H](O)C[C@@]2([C@@]1(C1)C(=O)CO)C)N1CC1=CC=CC(Cl)=C1 AOSZTAHDEDLTLQ-AZKQZHLXSA-N 0.000 description 1
- 125000000954 2-hydroxyethyl group Chemical group [H]C([*])([H])C([H])([H])O[H] 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229940126657 Compound 17 Drugs 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000223218 Fusarium Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003139 biocide Substances 0.000 description 1
- 230000002599 biostatic effect Effects 0.000 description 1
- SASIATPWJJLYRR-UHFFFAOYSA-N butanoic acid;hexane Chemical compound CCCCCC.CCCC(O)=O SASIATPWJJLYRR-UHFFFAOYSA-N 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- AOGYCOYQMAVAFD-UHFFFAOYSA-N chlorocarbonic acid Chemical compound OC(Cl)=O AOGYCOYQMAVAFD-UHFFFAOYSA-N 0.000 description 1
- 238000003181 co-melting Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- ATDGTVJJHBUTRL-UHFFFAOYSA-N cyanogen bromide Chemical compound BrC#N ATDGTVJJHBUTRL-UHFFFAOYSA-N 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- HAMGRBXTJNITHG-UHFFFAOYSA-N methyl isocyanate Chemical compound CN=C=O HAMGRBXTJNITHG-UHFFFAOYSA-N 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 150000004885 piperazines Chemical class 0.000 description 1
- MXXWOMGUGJBKIW-YPCIICBESA-N piperine Chemical compound C=1C=C2OCOC2=CC=1/C=C/C=C/C(=O)N1CCCCC1 MXXWOMGUGJBKIW-YPCIICBESA-N 0.000 description 1
- 229940075559 piperine Drugs 0.000 description 1
- WVWHRXVVAYXKDE-UHFFFAOYSA-N piperine Natural products O=C(C=CC=Cc1ccc2OCOc2c1)C3CCCCN3 WVWHRXVVAYXKDE-UHFFFAOYSA-N 0.000 description 1
- 235000019100 piperine Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- GWQWBFBJCRDINE-UHFFFAOYSA-M sodium;carbamodithioate Chemical compound [Na+].NC([S-])=S GWQWBFBJCRDINE-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000012265 solid product Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D203/00—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom
- C07D203/04—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
- C07D203/06—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D203/08—Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring nitrogen atom
- C07D203/12—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
- C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
- C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
- C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D233/16—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/91—Nitro radicals
- C07D233/92—Nitro radicals attached in position 4 or 5
- C07D233/95—Nitro radicals attached in position 4 or 5 with hydrocarbon radicals, substituted by nitrogen atoms, attached to other ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/16—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms condensed with carbocyclic rings or ring systems
- C07D249/18—Benzotriazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/28—Nitrogen atoms
- C07D295/30—Nitrogen atoms non-acylated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Description
Przedmiotem wynalazku jest sposób wytwarza¬ nia nowych pochodnych 2-amido-2^piperazynylo- -l,l,l^tróijchloroetanu o wzorze 1, oraz ewentual¬ nie iich sold, o wlasciwoisiciach grzybo- ii baktecrio- bójczych.W zwiazku o wzorze 1 RA oznacza atom wodoru, grupa alkilowa, zawierajaca 1—17 atomów wegla ewentualnie podstawiona 1—3 atomami chlorowca, grupe alikenylowa zawierajaca 2—17 atomów wegla, grupe metoksylowa lub etoksylowa, grupe fenylo- wa, grupe 2,4-dwuchlorofenoksylowa lub grupe a-<2,4-dwiuchlorofenoksy)-etylowa, a R2 oznacza grupe o wzorze —NO, —CN, grupe o wzorze 5, grupe o wzorze 6, o wzorze 7, o wzorze 8, o wzo¬ rze 9, a wystepujace we wzorach 6, 7, 8 i 9 sym¬ bole maja nastepujace znaczenie: R3 oznacza wo¬ dór, równowaznik w postaci kationu sodu, potasu, amonu, cynku, miedzi dwuwartosciowej, dwuwar- toscioweigo manganu, R^ oznacza wodór, grupe al¬ kilowa o 1—10 atomach wegla, ewentualnie pod¬ stawiona 1—3 atomami chlorowca, grupe fenylowa lub 2,4^-dwuchlorofen'oksymetylowa, R5 oznacza wodór, grupe alkilowa o d—1<2 atomach wegla, ewentualnie podstawiona 1—3 atomami chlorowca luib grupa metoksylowa, grupe cykloheksylowa, grupe o wzorze 10, grupe allilowa, fenylowa, R6 oznacza wodór, grupe fenylowa ewentualnie pod¬ stawiona 1—2 atomami chlorowca, grupe allilowa, alkilowa o 1—4 atomach wegla, benzylowa, R7 oznacza wodór, grupe metylowa, etylowa.Wedlug wynalazku nowe zwiazki wytwarza sie przez reakcje zwiazku o wzorze 2, w którym Ri ma znaczenie podane wyzej, ze srodkiem acylu- jacym.Zwiazki wyjsciowe o wzorze 2 lub ich sole wy¬ twarza isiie przez reakcje zwiajziku o wzioirzie 3, w którym R oznacza latwo odszczepialna anionowo reszte, nip. chlor, brom lub reszte kwasu sulfono¬ wego, z piperazyna z dokladnie zdefiniowana war¬ toscia pH. Jezeli pracuje sie przy wyzisnej niz kaz¬ dorazowa optymalna wartosc pH, wówczas powsta¬ ja przewaznie symetryczne dwupodstawione zwiaz¬ ki o wzorze 4, a przy nizszych od optymalnej war¬ tosciach pH nie zachodzi reakcja. Zwiazki o wzo¬ rze 2 i ich sole sa sufositiraitan:ii sitoisowismyimi do otrzymywania znacznej liczby asymetrycznie pod¬ stawionych piperazyn i dlateglo stanowia cenny produkt przejsciowy w produkcji biocydowych substancji czynnych.Ze zwiazków o wzorze 1 mozna wytwarzac w znany sposób sole.Zwiazki o wzorze 1 i ich sole sa substancjami czynnymi wykazujacymi róznorodne, imteireisiujace wlasciwosci biocydowe lub biostatyczne. Stosuje sie je do zwalczania róznych grzybów i bakterii wywolujacych choroby roslin i ludzi, np. do zwal¬ czania trwalych grzybni maczniaka, grzybów z ro¬ dziny Aspergillus, Xanthoimcnias, Bseudomoniais i Fusarium, oraz do zwalczania robaków i pierwot¬ niaków wywolujacych choroby ludzi i zwierzat. 9196691966 3 Do zwiatoamaa ginzybnd majazniaka trwalego szcze¬ gólnie odpowiednie sa wytworzone sposobem we¬ dlug wynalazku zwiazki o ozmiaczia atom wodoru.Do zwalczania tych szkodników stosuje sie pre- 5 paraty w postaci optymalnie dobranych zestawów zawierajacych co najmniej jedna z substancji czynnych o wzorze 1 lub ewentualnie jej sól oraz dodatkowe substancje pomocnicze, takie jak roz¬ puszczalniki, rozcienczalniki, nosniki, srodki zwil- io zajace, zwiekszajace przyczepnosc, emulgujace, dyspergujace i ewentualnie znane srodki biocy- dowe.Nowe srodki mozna stosowac w postaci zawie¬ sin, srodków do opylania, granulatów, roztworów, 15 koncentratów emulsyjnych, emulsji lub preparatów cfo opryskiwania; Stosowane stezenia substancji czynnej utrzymuje sie w granicach 0,00001—1%, korzysfame 0,001-hO„5%. Srodki do opylania i kom¬ pozycje ULV moga zawierac substancje czynne w 20 wyzszych stezeniach.Nizej podane przyklady wyjasniaja blizej wy¬ nalazek, nie oigraniczajac jego zakresu.Przyklad la. Odczyin roztworu 34,4 g pipe¬ razyny w 2200 ml wody doprowadza sie do war- 25 tosci pH = 4,0 przez dodanie 2n kwasu solnego (potrzeba okolo 500 ml tego kwasu). Silnie mie¬ szajac wkrapla sie równoczesnie roztwór 84,0 g N- acetonu i stezony wodny roztwór 80 g octanu so- 30 - dowego. Dodatek octanu sodowego dozuje sie tak, aby odczyn roztworu wykazywal wartosc pH = 4,0 ± 04. Po zakonczeniu dodawania roztworów mieszanine miesza sie jeszcze w ciagu 15 minut w temperaturze pokojowej. Po odsaczeniu malych 35 ilosci wytraconej N,N'-bisH(l^foiTmamido-2,2,2-tTÓj- chloroetylo)-pi|perazyny roztwór zadaje sie 200 ml % lugiu sodowego chlodzac do temperatury 5°C.Nastepnie dodaje sie 200 ml chlorku metylenu, oddziela warstwe wodna i nasyca ja weglanem 40 potasowym. Wytracony bezfoairwiny, kryisteliiiCEiny osad odsacza sie pod zmniejszonym cisnieniem i Drzekrystalizowuje z acetonu. Otrzymany zwiazek o wzorze 11 jest rozpuszczalny w wodzie i wyka¬ zuje temperature topnienia 122—123°C. 45 Z zasady N-(l,2,2-czterochloroetylo)-piperazyno- wej i obliczonej ilosci kwasu solnego otrzymuje sie po dokonanym odparowaniu chlorowodorek.Temperatura topnienia 182°C (z rozkladem). b) Do silnie mieszanej mieszaniny 3,2 g bromu 50 i 40 ml wody wkrapla sie roztwór 1,4 g cyjanku potasowego w 15 ml wody. Po zniknieciu bromo¬ wego zabarwienia do bromocyjanowego roztworu mieszajac dodaje sie malymi porcjami 5,2 g N[(l- -formamido-2,2,2-trójchloro)-etylo]Hpiiperazyny, po 55 czym wprowadza sie 2,06 g weglanu sodowego i miesza w temperaturze pokojowej w ciagu 2 go¬ dzin. Wytracony osad odsacza sie pod zmniejszo¬ nym cisnieniem i suszy w temperaturze pokojo¬ wej. W celu oczyszczenia surowy produkt rozpusz- 60 cza sie w chloroformie, otrzymany roztwór w przy¬ padku potrzeby przesacza sie i kroplami zadaje eterem. Otrzymuje sie bezbarwny krystaliczny zwiazek o wzorze 12, który wykazuje temperature topnienia 109-^110°C. «5 Przyklad II. Do roztwotu %fi % N-C(l-iform£l- midio-2,2,2^róflcMoro)-etylo]Hp(ipeiEazyiny, m 20 ml czterowodoirofuranu w temperaturze SO^C, inten¬ sywnie mieszajac wkrapla sie 0,76 g dwusiarczku wegla w 10 ml czterowodorofuranu a nastepnie mi 2n lugu sodowego. Calosc miesza sie w tem¬ peraturze pokojowej w ciaigu 1 ^godzmy^oddesity- lowuje czterowodorofiuran pod próznia na lazni o temperaturze 40°C, pozostalosc rozciera sie z ete¬ rem izopropylowym, odsacza pod zmniejszonym cisnieniem i suszy w temperaturze pokojowej.Otrzymuje sie dwutiokarbaminian sodowy w po¬ staci zóltawych krysztalów.Do roztworu 3,6 g tej soli sodowej w 60 ml etanolu mieszajac wkrapla sie roztwór 0,7 g chlor¬ ku cynkowego w 50 ml etanolu; Calosc miesza sie w temperaturze pokojowej w ciagu 30* minut i za¬ daje 150 ml wody. Wytracony osad odsacza sie pod zmniejszonym cisnieniem, przemywa woda i siuszy w temperaturze 50°C. Otrzymany zwiazek o wzorze 13 wykazuje temperature topnienia 250°C Oz rozkladem).Przyklad III. Roztwór 3,9 g N-(l-formami- do-2,2.,2-trójchloroetylo)Hpiiperazyny w 10 ml czte¬ rowodoroiuranu po dodaniu 1,22 g bezwodnika oc¬ towego ogrzewa sie do wrzenia w ciagu 2 godzin.Ochlodzony roztwór wylewa sie na lód, a wytra¬ cony pólstaly produkt ekstrahuje 5 porcjami chlor¬ ku metylenu o objetosci 15 ml kazda. Ekstrakt su¬ szy sie nad siarczanem sodowym a odparowuje.Surowy produkt przekrystalizowuje sie z miesza¬ niny izopropanol/heksan. Otrzymany produkt o wzorze 14 wykazuje temperature topnienia 140^150°C.Przyklad IV. Do roztworu 2,6 g N-[i(l-forma- mido-2,2,2-trójchloro)-etylo]ipiperazyny i 1,1 g trójetyloaminy w 30 ml metyloetyloketonu, miesza¬ jac wkrapla sie roztwór 1,6 g estru czterowodooro- furfuTylowego kwasu chloromrówkowego w 20 ml metyloetyloketonu. Meszanine ogrzewa sie do wrzenia w iciagu 10 miiinut, ochladza i wlewa do wody z lodem. Wydzielony olej ekstrahuje sie benzenem, ekstrakt przemywa sie woda, suszy nad siarczanem sodowym i odparowuje pod próznia.Oleisty surowy produkt krystalizuje sie przez roz¬ cieranie z heksanem. Otrzymany krystaliczny pro¬ dukt o wzorze 15 wykazuje temperature topnienia 72—75aC.Przyklad V. 2,6 g N-[(lHformamido-2,2,2- -trójchloro)-etylo]-piperazyny rozpuszcza sie w ml 2n kwasu solnego, chlodzi roztwór do tem¬ peratury 5°C i dodaje roztwór 0,97 g cyjanianu potasowego w 20 ml wody. Po 30-minutowym mie¬ szaniu w temperaturze pokojowej rozpuszcza sie stracanie bezbarwnego osadu. Po pozostawieniu w temperaturze pokojowej w ciagu 20 godzin, wy¬ tracony osad odsacza sie, przemywa woda i suszy w temperaturze ponizej 50°C Otrzymany produkt o wzorze 16 wykazuje temperature topnienia 175—176°C.Przyklad VI. Do roztworu 2,6 g N-[(l-fór- maimido-2^,2-trójchloro)-etylo]ipiperazyny w 10 ml aibsolutnego czterowodorofuran u dodaje sie 0,71 ml izocyjanianu metylu. Mieszanine pozosta¬ wia sie w temperaturze pokojowej przez 18 godzin,91 966 oiddestylowuje czterowodorofuran w prózni i prze- krysitalizowuje stala pozostalosc z ukladu izopropa- nol/heksan. Otrzymany zwiazek o wizorze 17 top¬ nieje w temperaturze 166—167°iC (rozklad). Analo¬ gicznie do powyzszych przykladów wytwarza sie nastepujace zwiazki: Tablica 1 Zwiazki o wzorze 18 Nr 1 1 2 3 4 6 7 8 9 11 12 13 14 j 16 17 18 19 R2 2 CHO COOH CH3 NO wzór 19 CH2CH2OH CO— -C(CH3)3 CO—C6H5 wzór 20 CH3—C— —CO C2H5—O— —CO (CH3)2CHO —CO CC1,CH20 —CO CH30— —CH2CH20 —SO wzór 21 C6H50—CO C6H5NH— —CO CH2 =CH— —CH2NH— —CO (CH3)2-N —CO Temperatura topnienia °C (przekrystalizowany z) 3 98—100 (etanol) 77—80 (etanol)woda 143—144 (toluen) 92—95 —¦ — 189—190 (rozklad) (izopropanol) 194 (rozklad) 190—191 (rozklad) 145 (metyloetyloketon) woda 110—112 (eter etylowy) 128 148—150 (etanol/woda) 94—96 138—140 (metyloetyloketon) woda 175 165—168 (toluen) 171 (aceton) 124—126 (octan etylu) heksan Uwagi 4 nierozpusz¬ czalny w rozcignczo- i nych lugach i jasnobrazo- wa zywica zóltawy wosk PL PL PL PL PL PL PL
Claims (1)
1. Z a s t rz e z e ini e patentowe Sposób wytwarzania nowych pochodnych 1,1,1- -trójchloroetanu o wzorze ogólnym 1, w którym Ri oznacza atom wodoru, grupe alkilowa o 1—17 atomach we^la, ewentualnie podstawiona 1—3 ato¬ mami chlorowca, grupe alkenylowa o 1—17 ato- 4hach wegla, grupe cmetoikisylowa lub etoiksylowa, grupe fenylowa, grupe 2,4-dwuchlorofeinoksymety- lowa, grupe a-i(i2,4-dwuchlorofenoksy)-etylowa, R2 oznacza grupe o wzorze —NO, o wzorze —CN—, o wzorze 5, grupe o wzorze 6, 7," 8 i 9, przy czym we wzorach 6—9, R3 oznacza atom wodoru, równo¬ waznik w postaci kationu sodu, potasu, amonu, 10 15 20 25 30 35 40 45 50 55 Nr 1 1 1 1 2 13 4 5 < 6 7 8 9 10 11 12 13 14 Ri 1 2 CH3 CH3 CH2C1 * (CH3)3C (CH3)3C n-C7Hn n-C]7H35 n-C]7H35 QH5 C6H5 QsH5 QH5 C6H50 C2H50 Tabli c a II Zwiazki o wzorze 1 R, 3 CH3 NO CH5 CH3 NO NO CH3 NO CH3 NO HO— —CH2CH2 (CH3)2N- -(CH2), NO CHO Temperatura topnienia w °C (przekrysta¬ lizowany z) 4 127—128 109—Fil 186—188 (rozklad) 124—126 (heksan) 148—150 76—77 100—103 — 113—115 184—185 126—128 (benzen/ /heksan) 202—204 • 95—97 (benzen/ /heksan) Uwagi 1 5 po" ogrze¬ waniu do wrzenia z heksanem po ogrze¬ waniu do wrzenia z heksanem jasnozólty lepki olej po ogrze¬ waniu do wrzenia z heksanem temperatura topnienia dwuchloro- wodorku bezbarwny olej Analiza: wyliczono: C 32,5% H 4,6% N 16,9% znaleziono: j C 32,3% H 4,6% N 16,6% 65 cynku, miedzi dwuwartosciowej i dwuwartosciowe- igo manganu, R4 oznacza wodór, grupe alkilowa o 1—10 atomach we^La, ewentualnie podstawiona 1—3 atomami chlorowca, grupe alkenylowa o 2—3 atomach wegla, grupe fenylowa, grupe 2,4-dwu- chlorofenoksymetylowa, R5 oznacza wodór, grupe alkilowa o 1—12 atomach wejgla ewentualnie pod¬ stawiona 1—3 atomami chlorowca luib grupe me- toksylowa, grupe cykloheksylowa, grupe o wzorze 11, grupe allilowa, fenylowa, Re oznacza wodór, gruipe benzylowa, fenylowa ewentualnie podstawio¬ na 1—2 atamiami lohloirtcrwioa, grupe allilowa, grupe alkilowa o 1—4 atomach wegla, R7 oznacza wodór, grupe metylowa, etylowa, znamienny tym, ze zwia¬ zek o wzorze 2, w którym Rt ma wyzej podane znaczenie, ipoiddaje sie ireakcji ze srcdlkiem acyluja- cym i otrzymany zwiazek 01 wzorze 1 ewentualnie prziqprowadzia w znany sposób w sól.91966 fc-CO-NH-CH-N N-R, CCl3 WZdR 1 R.-CO-NH-CH-N NH I CCL3 WZ(5R2 LJ" R^CO-NH-CH-R CCI, WZClR 3 RrCO-NH-CH-N N-CH-NH-CO-R, 1 I \_/ I CC13 CCL3 WZÓR 4 -c s NH m WZÓR 5 O II -C-SR3 WZdR 6 O II -C-R4 WZdR 7 O II -C-0R5 WZdR 8 O -c-n; u WZdR 9 TT CH2" WZdR 10 HN N-CH-NH-CHO ecu WZdR 1191 966 NC-N N-CH-NH-CHO CCL3 WZdR 12 H,N-CO-N N-CH-NH-CHO 2 v_/ i CCL3 WZdR 16 CCL-CH-NH-CHO 3 l .Nn Zn S=C-S WZdR 13 CH,-CO-N N-CH-NH-CHO 3 \ / I ecu CCL3 CH3-NH-C0-N^~N-CH-NH-CH0 WZdR 17 OHC-NH-CH-N N-R„ CCL WZdR 14 WZdR 18 O CHH3-CO-N7-^N-CH-NH-CHO 2 \ / i CCL3 WZdR 15 NH C^ XNH2 WZdR 19 0-CH2-C0 CL CL WZdR 20 <^T)-0-CO- WZdR 21 PL PL PL PL PL PL PL
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19691946112 DE1946112A1 (de) | 1969-09-11 | 1969-09-11 | 1,1,1-Trichloraethan-Derivate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL91966B1 true PL91966B1 (pl) | 1977-03-31 |
Family
ID=5745251
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1970143133A PL84078B1 (pl) | 1969-09-11 | 1970-09-10 | |
| PL1970177342A PL91966B1 (pl) | 1969-09-11 | 1970-09-10 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL1970143133A PL84078B1 (pl) | 1969-09-11 | 1970-09-10 |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US3707477A (pl) |
| JP (1) | JPS5224003B1 (pl) |
| AT (3) | AT312362B (pl) |
| BE (1) | BE756062A (pl) |
| CH (1) | CH545588A (pl) |
| CS (2) | CS173596B2 (pl) |
| DE (1) | DE1946112A1 (pl) |
| ES (2) | ES383503A1 (pl) |
| FR (1) | FR2061304A5 (pl) |
| GB (1) | GB1319479A (pl) |
| IL (1) | IL35271A (pl) |
| IT (1) | IT996012B (pl) |
| NL (1) | NL7013381A (pl) |
| PL (2) | PL84078B1 (pl) |
| RO (2) | RO67862A (pl) |
| SE (1) | SE391921B (pl) |
| YU (1) | YU35584B (pl) |
| ZA (1) | ZA706167B (pl) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3846430A (en) * | 1968-01-12 | 1974-11-05 | Bruneau & Cie Lab | 1-(2-methoxy-phenyl)-4-{8 2-(4-fluoro-benzamido)-ethyl{9 -piperazine |
| US3878223A (en) * | 1973-03-12 | 1975-04-15 | Abbott Lab | N-Substituted acrylamides |
| SE7500769L (pl) * | 1974-02-19 | 1975-08-20 | Ciba Geigy Ag | |
| DE2439610C2 (de) * | 1974-08-19 | 1986-01-23 | Výskumný ústav agrochemickej technologie, Bratislava-Predmestie | Fungicide Mittel auf der Basis von N-(1-Formamido-2.2.2-trichlorethyl)-morpholin |
| AT352119B (de) * | 1975-07-29 | 1979-09-10 | Celamerck Gmbh & Co Kg | Verfahren zur herstellung neuer imidazol-bzw. triazolderivate |
| US4146646A (en) * | 1976-02-12 | 1979-03-27 | Fisons Limited | Bis-amide fungicidal compounds |
| JPS52106836A (en) * | 1976-03-02 | 1977-09-07 | Kureha Chem Ind Co Ltd | N-trichloroacetyl-n#-chlorobenzoylhydrazine derivatives and germicide s for agriculture and horticulture containing thereof |
| FR2399408A1 (fr) * | 1977-08-03 | 1979-03-02 | Ugine Kuhlmann | Derives de dichloroacetamide et trichloroacetamide antidotes d'herbicides |
| JPS5859975A (ja) * | 1981-10-06 | 1983-04-09 | Kureha Chem Ind Co Ltd | N−〔1−トリアゾ−ル−(1)−イル−2,2,2−トリクロロエチル〕−置換アミド誘導体及び該誘導体を含有するうどんこ病防除剤 |
| PT77219B (fr) * | 1982-08-24 | 1986-02-04 | May & Baker Ltd | Procede de preparation des derives de la benzamide |
| US4452626A (en) * | 1982-09-20 | 1984-06-05 | Shell Oil Company | Herbicidal 4-(benzotriazol-1-yl)phenoxy)alkanoic acids, esters and salts |
| WO2003004476A1 (en) * | 2001-07-02 | 2003-01-16 | Ciba Specialty Chemicals Holding Inc. | Aminoalkyl-substituted benzotriazoles and triazoles as metal deactivators |
| KR20110044893A (ko) * | 2008-08-12 | 2011-05-02 | 알러간, 인코포레이티드 | 스핑고신-1-포스페이트 (s1p) 수용체 길항제 및 이의 사용 방법 |
-
0
- BE BE756062D patent/BE756062A/xx unknown
-
1969
- 1969-09-11 DE DE19691946112 patent/DE1946112A1/de active Pending
-
1970
- 1970-08-20 CS CS3680A patent/CS173596B2/cs unknown
- 1970-08-20 CS CS5749A patent/CS173572B2/cs unknown
- 1970-09-04 GB GB4254370A patent/GB1319479A/en not_active Expired
- 1970-09-08 CH CH1339470A patent/CH545588A/xx not_active IP Right Cessation
- 1970-09-09 ES ES383503A patent/ES383503A1/es not_active Expired
- 1970-09-09 SE SE7012284A patent/SE391921B/xx unknown
- 1970-09-10 JP JP45078930A patent/JPS5224003B1/ja active Pending
- 1970-09-10 US US71262A patent/US3707477A/en not_active Expired - Lifetime
- 1970-09-10 PL PL1970143133A patent/PL84078B1/pl unknown
- 1970-09-10 IT IT53330/70A patent/IT996012B/it active
- 1970-09-10 IL IL35271A patent/IL35271A/en unknown
- 1970-09-10 PL PL1970177342A patent/PL91966B1/pl unknown
- 1970-09-10 NL NL7013381A patent/NL7013381A/xx unknown
- 1970-09-10 ZA ZA706167A patent/ZA706167B/xx unknown
- 1970-09-11 AT AT751471A patent/AT312362B/de not_active IP Right Cessation
- 1970-09-11 RO RO7000064434A patent/RO67862A/ro unknown
- 1970-09-11 FR FR7033024A patent/FR2061304A5/fr not_active Expired
- 1970-09-11 AT AT725771A patent/AT302331B/de not_active IP Right Cessation
- 1970-09-11 AT AT828270A patent/AT303053B/de not_active IP Right Cessation
- 1970-09-11 RO RO7077239A patent/RO73179A/ro unknown
- 1970-09-11 YU YU2264/70A patent/YU35584B/xx unknown
-
1971
- 1971-10-19 ES ES396134A patent/ES396134A1/es not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| NL7013381A (pl) | 1971-03-15 |
| PL84078B1 (pl) | 1976-02-28 |
| FR2061304A5 (pl) | 1971-06-18 |
| IL35271A (en) | 1974-11-29 |
| ZA706167B (en) | 1971-05-27 |
| SE391921B (sv) | 1977-03-07 |
| CS173596B2 (pl) | 1977-02-28 |
| RO67862A (fr) | 1979-01-15 |
| IT996012B (it) | 1975-12-10 |
| JPS5224003B1 (pl) | 1977-06-28 |
| AT312362B (de) | 1973-12-27 |
| RO73179A (ro) | 1982-10-11 |
| YU226470A (en) | 1980-10-31 |
| AT302331B (de) | 1972-10-10 |
| IL35271A0 (en) | 1970-11-30 |
| YU35584B (en) | 1981-04-30 |
| ES396134A1 (es) | 1974-04-16 |
| DE1946112A1 (de) | 1971-03-18 |
| BE756062A (fr) | 1971-03-11 |
| GB1319479A (en) | 1973-06-06 |
| AT303053B (de) | 1972-11-10 |
| CS173572B2 (pl) | 1977-02-28 |
| ES383503A1 (es) | 1973-04-16 |
| US3707477A (en) | 1972-12-26 |
| CH545588A (pl) | 1974-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL91966B1 (pl) | ||
| US3493574A (en) | 2-amino pyrimidinyl-6-carbamates and salts thereof | |
| US3665078A (en) | N-trityl-imidazoles as plant fungicides | |
| US3965107A (en) | Isothiazolopyridinones | |
| FI64144C (fi) | Foerfarande foer framstaellning av 2-arylamino-2-imidazolinderivat | |
| DE69011179T2 (de) | Heterocyclische Dione als Pestizide und Pflanzenwuchsregulatoren. | |
| AU606089B2 (en) | Substituted-amido derivatives, method for preparation of the same and phytopathogenic fungicides containing the same | |
| CN108440519B (zh) | 一种噁二唑邻苯乙氧基类化合物与用途 | |
| IE47467B1 (en) | Imidazoline derivatives and their salts | |
| US4108859A (en) | Microbicidal (pyridinylamino) alkyl guanidines | |
| EP0098953B1 (de) | Substituierte Maleinsäureimide, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel | |
| US4022607A (en) | Substituted oxazoles and thiazoles as herbicides | |
| US4038387A (en) | 1-dimethylcarbamyl-3-branched alkyl-1,2,4-triazol-5-yl-(n-substituted) sulfonamides and their use as insecticides | |
| EP0109575A2 (de) | Benzoesäurederivate, Verfahren und Mittel zu deren Herstellung | |
| EP0117482B1 (de) | Substituierte Maleinsäureimide und deren Verwendung als Schädlingsbekämpfungsmittel | |
| US3973028A (en) | 1-Dimethylcarbamyl-3-branched alkyl-1,2,4-triazol-5-yl-(N-substituted) sulfonamides and use as insecticides | |
| US3943154A (en) | Acylamides of beta-cyano-ethenesulfonyl substituted aminoarenes | |
| DE3306996A1 (de) | Acrylsaeuremorpholide, ihre herstellung und verwendung | |
| JPS6160666A (ja) | 置換アリールスルホニルグアニジン及びその酸付加物 | |
| PL87623B1 (pl) | ||
| US3655688A (en) | N-alkoxy-2-benzimidazole carboximidoyl chlorides | |
| US3523951A (en) | 1,3,4-thiadiazole-5(4h)-one derivatives | |
| EP0170057B1 (de) | Verfahren zur Herstellung von N-Phenyl(Pyridyl)-sulfonyldiamiden | |
| JP3064371B2 (ja) | ベンゾオキサジルウラシル誘導体、その製造法およびそれを有効成分とする除草剤 | |
| KR800001546B1 (ko) | 3,4-디치환벤족사(티아)졸론 유도체의 제조방법 |